MORRONE, DORALISA
 Distribuzione geografica
Continente #
NA - Nord America 4.784
AS - Asia 2.368
EU - Europa 1.876
SA - Sud America 387
AF - Africa 121
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 3
Totale 9.548
Nazione #
US - Stati Uniti d'America 4.679
SG - Singapore 827
CN - Cina 635
IT - Italia 562
HK - Hong Kong 475
SE - Svezia 393
BR - Brasile 325
DE - Germania 287
VN - Vietnam 170
BG - Bulgaria 154
FI - Finlandia 108
RU - Federazione Russa 95
GB - Regno Unito 88
TR - Turchia 74
CA - Canada 72
FR - Francia 47
CI - Costa d'Avorio 46
IN - India 36
AT - Austria 35
AR - Argentina 26
JP - Giappone 22
MX - Messico 20
NG - Nigeria 20
KR - Corea 19
BD - Bangladesh 17
ZA - Sudafrica 16
UA - Ucraina 15
ID - Indonesia 14
IQ - Iraq 14
PL - Polonia 12
SN - Senegal 12
EC - Ecuador 11
SA - Arabia Saudita 11
BE - Belgio 10
CO - Colombia 10
CZ - Repubblica Ceca 10
ES - Italia 9
MA - Marocco 8
NL - Olanda 8
CH - Svizzera 6
GR - Grecia 6
PE - Perù 6
AE - Emirati Arabi Uniti 5
AU - Australia 5
EG - Egitto 5
IE - Irlanda 5
TW - Taiwan 5
AZ - Azerbaigian 4
KZ - Kazakistan 4
MY - Malesia 4
NZ - Nuova Zelanda 4
PH - Filippine 4
UZ - Uzbekistan 4
BY - Bielorussia 3
CL - Cile 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
ET - Etiopia 3
HN - Honduras 3
HU - Ungheria 3
IR - Iran 3
JO - Giordania 3
LK - Sri Lanka 3
LT - Lituania 3
PK - Pakistan 3
RO - Romania 3
RS - Serbia 3
VE - Venezuela 3
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
EU - Europa 2
GE - Georgia 2
HR - Croazia 2
IL - Israele 2
JM - Giamaica 2
KE - Kenya 2
KG - Kirghizistan 2
LU - Lussemburgo 2
PY - Paraguay 2
AL - Albania 1
AM - Armenia 1
BB - Barbados 1
BJ - Benin 1
BW - Botswana 1
CD - Congo 1
CR - Costa Rica 1
GT - Guatemala 1
LV - Lettonia 1
ML - Mali 1
MU - Mauritius 1
NP - Nepal 1
PA - Panama 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 9.548
Città #
Ashburn 568
Hong Kong 464
Singapore 403
Woodbridge 394
Dallas 380
Santa Clara 380
Fairfield 345
Houston 301
Chandler 274
Ann Arbor 252
Shanghai 191
Seattle 162
Munich 158
Sofia 154
Serra 148
New York 135
Wilmington 135
Cambridge 131
Beijing 123
Milan 86
Boardman 85
Princeton 83
Los Angeles 79
Lawrence 67
Helsinki 56
Medford 56
Florence 55
Pisa 48
Abidjan 46
Dearborn 41
Buffalo 37
Ottawa 37
São Paulo 36
London 35
Des Moines 34
Izmir 34
Ho Chi Minh City 33
Dong Ket 32
Chicago 30
Istanbul 29
Frankfurt am Main 27
Hefei 26
Redondo Beach 26
Vienna 25
Hanoi 24
Nanjing 23
San Diego 20
Rome 19
Tokyo 19
Düsseldorf 18
Lagos 18
Seoul 16
Turku 15
Jacksonville 14
Ogden 14
Council Bluffs 12
Dakar 12
Fuzhou 12
Guangzhou 12
Lucca 12
San Francisco 12
Lancaster 11
Nuremberg 11
Jiaxing 10
Redwood City 10
Shenyang 10
Toronto 10
Warsaw 10
Brussels 9
Mexico City 9
Poplar 9
Beauharnois 8
Johannesburg 8
Mcallen 8
Nanchang 8
Phoenix 8
Wuhan 8
Brooklyn 7
Cascina 7
Changsha 7
Charlotte 7
Curitiba 7
Denver 7
Indiana 7
Norwalk 7
Orem 7
Paris 7
Quanzhou 7
Stockholm 7
Changzhou 6
Chennai 6
Falls Church 6
Livorno 6
Montreal 6
Porto Alegre 6
Quito 6
Boston 5
Brasília 5
Bremen 5
Capannori 5
Totale 6.806
Nome #
Influence of depression and anxiety on circulating endothelial progenitor cells in patients with acute coronary syndromes 284
Role of circulating endothelial progenitor cells in the reparative mechanisms of stable ischemic myocardium 230
Arterial hypertension and atrial fibrillation: standard and advanced echocardiography from diagnosis to prognostication 223
Pharmacological Agents Targeting Myocardial Metabolism for the Management of Chronic Stable Angina : an Update 195
Obstructive coronary atherosclerosis and ischemic heart disease: An elusive link! 193
Influence of depression and anxiety on circulating endothelial progenitor cells in patients with acute coronary syndromes 192
Circulating endothelial progenitor cells are actively involved in the reparative mechanisms of stable ischemic myocardium 190
Trimetazidine 183
Pharmacological approaches to coronary microvascular dysfunction 177
Prognostic value of cardiac power output to left ventricular mass in patients with left ventricular dysfunction and dobutamine stress echo negative by wall motion criteria 176
Determination of volatile organic compounds in human breath for monitoring heart failure patients 169
Stress Testing After Complete and Successful Coronary Revascularization 163
Resting heart rate is an independent predictor of left ventricular diastolic dysfunction in obese patients with or without arterial hypertension 161
Myocardial protection during PCI in STEMI : strategy reperfusion effects in acute MI patients (stream study) 160
Feasibility and functional correlates of left atrial volume changes during stress echocardiography in chronic coronary syndromes 154
Trimetazidine and Other Metabolic Modifiers 153
Appropriateness of use criteria in echocardiography: an Italian experience 148
Endothelial progenitor cells: An appraisal of relevant data from bench to bedside 147
The second law of thermodynamics and the heart 145
Lipid-altering efficacy of ezetimibe plus statin and statin monotherapy and identification of factors associated with treatment response : a pooled analysis of over 21,000 subjects from 27 clinical trials 144
Pre-PCI angina post-PCI ischaemia: tales of ordinary madness 143
Lung Ultrasound and Pulmonary Congestion During Stress Echocardiography 142
Sex-related differences in chronic heart failure 139
Organization and Activity of Italian Echocardiographic Laboratories: A Survey of the Italian Society of Echocardiography and Cardiovascular Imaging 137
Trials in ischemic heart disease do not represent the ischemic universe 136
Safety profile of statins alone or combined with ezetimibe : a pooled analysis of 27 studies including over 22,000 patients treated for 6-24 weeks 135
Ultrasound assessment of left ventricular force-frequency relationship to risk stratify patients with advanced chronic systolic heart failure 133
The central role of invasive functional coronary assessment for patients with ischemic heart disease 131
Antianginal Therapy for Stable Ischemic Heart Disease 130
Prediction of post percutaneous coronary intervention myocardial ischaemia 130
Interventional cardiology : Cost-effectiveness of PCI guided by fractional flow reserve 130
Reply letter to Dr. Xu et al. on role of circulating endothelial progenitor cells in the reparative mechanisms of stable ischemic myocardium 126
Do clinical trials in ischemic heart disease meet the needs of those with ischemia? 125
Postconditioning 124
Higher 30-day readmission rate for suspicion of ACS : effect of kidney function 120
A narrative overview: Have clinical trials of PCI vs medical therapy addressed the right question? 119
Controversies in fractional flow reserve 117
Feasibility and value of two-dimensional volumetric stress echocardiography 114
The importance of integrated left atrial evaluation: From hypertension to heart failure with preserved ejection fraction 112
Prognostic value of stress echocardiography assessed by the ABCDE protocol 111
Interactions between coronary stenoses and microcirculation 110
Perspectives in noninvasive imaging for chronic coronary syndromes 109
The Role of Nitrates in the Management of Stable Ischemic Heart Disease: A Review of the Current Evidence and Guidelines 109
Resistant hypertension: an overview 108
Hemodynamic heterogeneity of reduced cardiac reserve unmasked by volumetric exercise echocardiography 107
null 102
Reshaping of italian echocardiographic laboratories activities during the second wave of covid-19 pandemic and expectations for the post-pandemic era 101
Stress echo 2030: The novel ABCDE-(FGLPR) protocol to define the future of imaging 100
Myocardial ischemia: From disease to syndrome 98
Long-term follow-up of elective chronic total coronary occlusion angioplasty: Analysis from the U.K. central cardiac audit database 98
Myocardial ischemia as a multifactorial: Disease: What is new? 97
Casual diagnosis of abdominal aorta aneurysm during transthoracic echocardiographic test: Clinical case and literature review 97
The new clinical standard of integrated quadruple stress echocardiography with ABCD protocol 97
Pancreatitis-associated Myocarditis: Systematic Review and Meta-analysis of a Deadly Duo 96
Left atrial volume changes during exercise stress echocardiography in heart failure and hypertrophic cardiomyopathy 95
null 93
Role of RAAS inhibition in preventing left ventricular remodeling in patients post myocardial infarction 93
SAFETY OF NOVEL ORAL ANTICOAGULANTS COMPARED TO VITAMIN K ANTAGONISTS IN THE TREATMENT OF VENOUS THROMBOEMBOLISM: A SYSTEMATIC REVIEW AND META-ANALYSIS 90
Radiation Exposure is Incresead Through the Last Ten Years 90
Efforts to decrase the door to balloon time might increase the incidence of unnecessary emergency cardiac catheterization and delay appropriate care 89
null 89
The ESC ACCA EAPCI EORP acute coronary syndrome ST-elevation myocardial infarction registry 89
Echocardiographic assessment of coronary microvascular dysfunction: Basic concepts, technical aspects, and clinical settings 89
Bleeding risk score: limits and practicability 85
Therapy against ischemic injury 84
Sex-related differences in ventricular remodeling after myocardial infarction 83
Diagnostic approach for coronary microvascular dysfunction in patients with chest pain and no obstructive coronary artery disease 81
Microvascular function/dysfunction downstream a coronary stenosis 80
Ivabradine in Cardiovascular Disease Management Revisited: a Review 76
null 75
Acute pulmonary embolism: Focus on the clinical picture 73
Mortality Prediction of the CHA2DS2-VASc Score, the HAS-BLED Score, and Their Combination in Anticoagulated Patients with Atrial Fibrillation 72
Integrated quadruple stress echocardiography 67
HIT initiative: Discussion with the seniors 66
Myocardial infarction with nonobstructive coronary arteries: from pathophysiology to therapeutic strategies 64
null 64
Trials in ischemic heart disease do not represent the ishemic universe 64
Pulmonary Congestion During Exercise Stress Echocardiography in Ischemic and Heart Failure Patients 63
Persistent angina: the Araba Phoenix of cardiology 56
In-stent restenosis after percutaneous coronary intervention: emerging knowledge on biological pathways 46
Right ventricular dysfunction is associated with chronic kidney disease and predicts survival in patients with chronic systolic heart failure. 46
Myocardial 123I-metaiodobenzylguanidine imaging in hypertension and left ventricular hypertrophy 46
Clinical outcomes of patients with coronary microvascular dysfunction in absence of obstructive coronary atherosclerosis 45
Totale 9.723
Categoria #
all - tutte 30.238
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.238


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021246 0 0 0 0 0 14 9 43 29 49 23 79
2021/2022767 8 22 22 38 142 109 34 25 46 34 64 223
2022/20231.001 163 161 84 33 111 113 7 84 156 7 55 27
2023/2024697 44 67 77 43 87 153 26 36 13 22 37 92
2024/20252.625 22 85 42 136 262 311 279 118 326 336 233 475
2025/20261.938 233 332 453 321 361 238 0 0 0 0 0 0
Totale 9.723